- A preventable crisis: Tackling the long-term impacts of obesity on Australians’ health and prosperity:
A joint report by the McKell Institute and the Menzies Research Centre, commissioned by Novo Nordisk. - Productivity and Preventative Health Investment - The Queensland Resources Sector:
A Queensland Future Institute report, supported by Novo Nordisk - Novo Nordisk submission to the Economic Reform Roundtable 2025
- Novo Nordisk pre-budget submission 2025-2026: From strategy to action on chronic disease prevention and management
- [March 2026] Novo Nordisk signs MoU to pilot Australia’s first recycling initiative for medical injection pens
- [March 2026] Novo Nordisk and Murdoch Children’s Research Institute announce collaboration to advance youth‑centred obesity care across Pacific Island nations
- [March 2026] Danish Royals witness launch of new liver health collaboration for regional, rural and remote Queensland
- [March 2026] National Press Club address by Mike Doustdar, President and CEO of Novo Nordisk
- [February 2026] Australian-first program invests up to 3 million into Logan community
- [December 2025] Novo Nordisk Oceania raises over AUD $106,000 for type 1 diabetes research at Breakthrough T1D One Ride 2025
- [December 2025] Novo Nordisk Oceania Announces Arrival of Michael Azrak, GM Oceania
- [November 2025] Australian Melanoma Oncologist Honoured with Inaugural Marie Krogh Prize for Young Women in Science
- [August 2025] Novo Nordisk launches global-first Marie Krogh Young Women in Science Prize in Australia to champion the next generation of women in STEM
- [June 2025] Novo Nordisk teams up with Heart of Australia to expand clinical trial access in regional, rural and remote Queensland
- [March 2025] Novo Nordisk forms Aboriginal and Torres Strait Islander Health Advisory Council to advance health equity for Aboriginal and Torres Strait Islander Peoples
- [March 2025] Novo Nordisk Australia named on the 2025 Best Workplaces for WomenTM list